Advertisement
Screener

GUARDANT HEALTH, INC. (GH) Comprehensive Income

2.8 / 5 stars · 68/120 Roast Me

GUARDANT HEALTH, INC. Comprehensive Income

GUARDANT HEALTH, INC. (GH) reported Comprehensive Income of -$120.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30

  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$120.55M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$112.38M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$129.09M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$93.26M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$415.93M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$437.90M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$463.60M.
  • GUARDANT HEALTH, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$669.35M.
Period endComprehensive Income (Loss), Net of Tax, Attributable to Parent 3 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 6 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 9 monthComprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month
2026-06-30-$120.55M
10-Q · filed 2026-07-30
-$232.93M
10-Q · filed 2026-07-30
-$362.01M
derived: sum of 3 quarters · filed 2026-07-30
-$455.28M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$112.38M
10-Q · filed 2026-05-07
-$241.46M
derived: sum of 2 quarters · filed 2026-05-07
-$334.72M
derived: sum of 3 quarters · filed 2026-05-07
-$433.69M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31-$129.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$222.35M
derived: sum of 2 quarters · filed 2026-02-19
-$321.31M
derived: sum of 3 quarters · filed 2026-07-30
-$415.93M
10-K · filed 2026-02-19
2025-09-30-$93.26M
10-Q · filed 2025-10-29
-$192.23M
derived: sum of 2 quarters · filed 2026-07-30
-$286.84M
10-Q · filed 2025-10-29
-$399.76M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$98.96M
10-Q · filed 2026-07-30
-$193.58M
10-Q · filed 2026-07-30
-$306.50M
derived: sum of 3 quarters · filed 2026-07-30
-$411.90M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$94.62M
10-Q · filed 2026-05-07
-$207.54M
derived: sum of 2 quarters · filed 2026-05-07
-$312.94M
derived: sum of 3 quarters · filed 2026-05-07
-$416.41M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31-$112.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19
-$218.32M
derived: sum of 2 quarters · filed 2026-02-19
-$321.79M
derived: sum of 3 quarters · filed 2026-02-19
-$437.90M
10-K · filed 2026-02-19
2024-09-30-$105.40M
10-Q · filed 2025-10-29
-$208.87M
derived: sum of 2 quarters · filed 2025-10-29
-$324.98M
10-Q · filed 2025-10-29
2024-06-30-$103.47M
10-Q · filed 2025-07-30
-$219.58M
10-Q · filed 2025-07-30
2023-12-31-$463.60M
10-K · filed 2026-02-19
2023-03-31-$126.16M
10-Q · filed 2023-05-09
-$258.76M
derived: sum of 2 quarters · filed 2024-02-22
-$423.35M
derived: sum of 3 quarters · filed 2024-02-22
-$658.73M
derived: sum of 4 quarters · filed 2024-02-22
2022-12-31-$132.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$297.19M
derived: sum of 2 quarters · filed 2024-02-22
-$532.57M
derived: sum of 3 quarters · filed 2024-02-22
-$669.35M
10-K · filed 2024-02-22
2022-09-30-$164.59M
10-Q · filed 2022-11-03
-$399.96M
derived: sum of 2 quarters · filed 2022-11-03
-$536.74M
10-Q · filed 2022-11-03
-$631.82M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30-$235.38M
10-Q · filed 2022-08-04
-$372.16M
10-Q · filed 2022-08-04
-$467.24M
derived: sum of 3 quarters · filed 2024-02-22
-$575.39M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31-$136.78M
10-Q · filed 2023-05-09
-$231.86M
derived: sum of 2 quarters · filed 2024-02-22
-$340.01M
derived: sum of 3 quarters · filed 2024-02-22
-$438.46M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31-$95.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
-$203.23M
derived: sum of 2 quarters · filed 2024-02-22
-$301.68M
derived: sum of 3 quarters · filed 2024-02-22
-$413.13M
10-K · filed 2024-02-22
2021-09-30-$108.15M
10-Q · filed 2022-11-03
-$206.60M
derived: sum of 2 quarters · filed 2022-11-03
-$318.05M
10-Q · filed 2022-11-03
-$412.96M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30-$98.45M
10-Q · filed 2022-08-04
-$209.90M
10-Q · filed 2022-08-04
-$304.81M
derived: sum of 3 quarters · filed 2023-02-23
-$384.01M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$111.45M
10-Q · filed 2022-05-05
-$206.36M
derived: sum of 2 quarters · filed 2023-02-23
-$285.56M
derived: sum of 3 quarters · filed 2023-02-23
-$342.51M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$94.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$174.11M
derived: sum of 2 quarters · filed 2023-02-23
-$231.06M
derived: sum of 3 quarters · filed 2023-02-23
-$252.20M
10-K · filed 2023-02-23
2020-09-30-$79.20M
10-Q · filed 2021-11-04
-$136.15M
derived: sum of 2 quarters · filed 2021-11-04
-$157.29M
10-Q · filed 2021-11-04
-$182.50M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$56.95M
10-Q · filed 2021-08-05
-$78.09M
10-Q · filed 2021-08-05
-$103.30M
derived: sum of 3 quarters · filed 2022-02-24
-$116.32M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$21.14M
10-Q · filed 2021-05-06
-$46.34M
derived: sum of 2 quarters · filed 2022-02-24
-$59.37M
derived: sum of 3 quarters · filed 2022-02-24
-$69.96M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31-$25.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
-$38.23M
derived: sum of 2 quarters · filed 2022-02-24
-$48.82M
derived: sum of 3 quarters · filed 2022-02-24
-$74.46M
10-K · filed 2022-02-24
2019-09-30-$13.03M
10-Q · filed 2020-11-05
-$23.61M
derived: sum of 2 quarters · filed 2020-11-05
-$49.25M
10-Q · filed 2020-11-05
-$73.92M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$10.59M
10-Q · filed 2020-08-06
-$36.22M
10-Q · filed 2020-08-06
-$60.90M
derived: sum of 3 quarters · filed 2021-02-25
-$85.19M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$25.64M
10-Q · filed 2020-05-07
-$50.31M
derived: sum of 2 quarters · filed 2021-02-25
-$74.61M
derived: sum of 3 quarters · filed 2021-02-25
-$96.11M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31-$24.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$48.97M
derived: sum of 2 quarters · filed 2021-02-25
-$70.47M
derived: sum of 3 quarters · filed 2021-02-25
-$84.61M
10-K · filed 2021-02-25
2018-09-30-$24.30M
10-Q · filed 2019-11-07
-$45.80M
derived: sum of 2 quarters · filed 2019-11-07
-$59.94M
10-Q · filed 2019-11-07
-$75.39M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30-$21.50M
10-Q · filed 2019-08-07
-$35.64M
10-Q · filed 2019-08-07
-$51.09M
derived: sum of 3 quarters · filed 2020-03-02
-$79.68M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$14.14M
10-Q · filed 2019-05-10
-$29.59M
derived: sum of 2 quarters · filed 2020-03-02
-$58.18M
derived: sum of 3 quarters · filed 2020-03-02
2017-12-31-$15.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$44.03M
derived: sum of 2 quarters · filed 2020-03-02
-$83.67M
10-K · filed 2020-03-02
2017-09-30-$28.58M
10-Q · filed 2018-11-19
-$68.22M
10-Q · filed 2018-11-19
2016-12-31-$46.22M
10-K · filed 2019-03-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30